VivoSeq
Other

Rocuronium

0

Pipeline Programs

2

Active Trials

1

Companies Involved

Rocuronium is an early-stage landscape with 0 programs across 1 company. The most active players are Merck & Co..

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

26

clinical trials

Completed18 · 69%
Unknown status6 · 23%
Not yet recruiting1 · 4%
Recruiting1 · 4%

Trial Activity

26 trials

Succinylcholine vs Rocuronium for Prehospital Emergency Intubation
Completed··Phase 3·NCT02000674·1,321 enrolled
Magnesium Sulphate and Rocuronium in Patients Over 60
Completed··Phase 1·NCT01804205·64 enrolled
Effect of Rocuronium on BIS Values
Completed·UUniversity of Padova·N/A·NCT05681611·8 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)